One earnings short-squeeze play in the biotechnology and drugs complex is Spectrum Pharmaceuticals (SPPI), which is set to release numbers on Thursday before the market open. This company is engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. Wall Street analysts, on average, expect Spectrum Pharmaceuticals to report revenue of $52.73 million on earning of 31 cents per share.
If you're looking for a heavily shorted stock that's trading within range of a potential breakout post-earnings, then make sure to take a close look at shares of Spectrum Pharmaceuticals. This stock has been uptrending strong heading into the quarter since shares are just two points off its 52-week high of $16 a share.The current short interest as a percentage of the float for Spectrum Pharmaceuticals is extremely high at 29%. That means that out of the 49.35 million shares in the tradable float, 15.79 million are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 15.7%, or by about 2.14 million shares. >>5 Biotech Stocks for 2012 From a technical perspective, SPPI is currently trading above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock has been trading sideways for the past month and change between $16 on the upside and around $13 on the downside. A move outside of that range post-earnings should set this stock up for its next big trend. If you're bullish on SPPI, wait until after earnings and look for long biased trades if the stock breaks out above its 50-day moving average of $14.53 and above some near-term overhead resistance at $14.85 a share with high-volume. Look for volume that's tracking in close to or above its three-month average volume of 1.6 million shares. If we get that action, I would look for SPPI to re-test $16 and potentially take that level out if the bulls gain full control of this stock post-earnings. I would avoid any long trades or look for short biased trades in SPPI if after earnings this stock fails to move back above its 50-day moving average of $14.53 with strong volume. If we get that action, then SPPI could easily selloff back towards that near-term support at $13 a share, or possibly much lower if the bears whack this down post-earnings.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV